Methylprednisolone Market Forecasts for Global (2020) and China (2019) Regions in New Research Reports

DALLAS, July 8, 2015 /PRNewswire/ --

LifeScienceIndustryResearch.com adds two new methylprednisolone market research studies titled "Global Methylprednisolone Industry Report 2015" and "Investigation Report on China Methylprednisolone Market, 2010-2019" to the pharmaceuticals section of its library.

Complete report on global methylprednisolone market spread across 132 pages, talking about 6 major HDPE companies and supported with 164 tables and figures is now available at http://www.lifescienceindustryresearch.com/global-methylprednisolone-industry-report-2015.html .

Global methylprednisolone market report 2015-2020 is a professional and in-depth study on the current state of the Methylprednisolone industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Methylprednisolone market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans of the methylprednisolone market are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins. The report focuses on global major leading industry players of methylprednisolone market providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Methylprednisolone market development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 164 tables and figures to support the methylprednisolone market analysis, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market. Companies profiled in this methylprednisolone market report include ENDO, Sandoz, Jubilant Cadista, TEVA, Tianjin Kingyork and Xianju. Order a copy of Global Methylprednisolone Industry Report 2015 at http://www.lifescienceindustryresearch.com/purchase?rname=45234 .

Regionally, the market size of Methylprednisolone in China is expected to keep growing in the next few years according to the second research titled Investigation Report on China Methylprednisolone Market, 2010-2019. Methylprednisolone continues to grow after entering China with annual sales value rising from less than CNY 90 million in 2005 to CNY 295 million in 2014 and CAGR reaching up to 15%. Pharmacia & Upjohn (Belgium), Pharmacia & Upjohn (IT), Tianjin Tianyao Pharmaceuticals Co., Ltd , Pfizer Manufacturing Beglium NV and Rongsheng Pharmaceutical Co., Ltd all take up certain shares in the Chinese market, among which Pfizer Manufacturing Beglium NV has the largest market share of 43.7% in 2014 for sales value while Pharmia & Upjohn (IT) has the largest market share of 54.9% for sales volume.

The Investigation Report on China Methylprednisolone Market, 2010-2019 (http://www.lifescienceindustryresearch.com/investigation-report-on-china-methylprednisolone-market-2010-2019.html ) says ever since the 1990s, steroid has entered its golden age with over 120 varieties being made for application and sales value in the global market increasing by 10%-15% each year. During the process of product restructuring and industrial development, steroid's Active Pharmaceutical Ingredients (APIs) made in China take an important position in the global market. Out of all the varieties of steroid's APIs, half are made in China.

As a variety performing well in hospitals in recent years, Methylprednisolone, driven by clinical needs and brand effects, shows a trend of steady growth. Developed by Pharmacia & Upjohn, Methylprednisolone entered China in the late 1990s under the trade names of Medrol (Pfizer) and Solu-Medrol (Pharmacia & Upjohn). This research gives data and information on market size of Methylprednisolone in China, market share of manufacturers of Methylprednisolone in China, price of Methylprednisolone in Chinese market, major manufacturers of Methylprednisolone in Chinese market and market outlook of Methylprednisolone in China. Major Manufacturers of Chinese Methylprednisolone Market covered in this report include Rongsheng Pharmaceutical Co., Ltd, Tianjin Tianyao Pharmaceuticals Co., Ltd, Pharmacia & Upjohn (IT), Pfizer Manufacturing Beglium NV and Tianjin Kingyork Group Co., Ltd. Reference Price of Methylprednisolone in Chinese Hospitals in 2014 is provided in this report for Pfizer Manufacturing Beglium NV (Trade Name: Medrol), Nang Kuang Pharmaceutical Co., Ltd, Rongsheng Pharmaceutical Co., Ltd, Tianjin Tianyao Pharmaceuticals Co., Ltd, Tianjin Kingyork Group Co., Ltd, Pharmacia & Upjohn (IT) (Trade Name: Solu-Medrol) and Pharmacia & Upjohn (Belgium) (Trade Name: Solu-Medrol).

Order a copy of Investigation Report on China Methylprednisolone Market, 2010-2019 at http://www.lifescienceindustryresearch.com/purchase?rname=44388 .

Explore more reports on the pharmaceuticals market at http://www.lifescienceindustryresearch.com/category/pharmaceuticals .

About Us:  

Life Science Industry Research brings to you to the latest reports in market research on Biotechnology, Diagnostics, Healthcare, Medical Devices and Pharmaceuticals segments from leading research publishers across the globe. These reports also cover data and information on sub-segments and sectors under these life sciences categories.

Connect with Us: 

G+ / Google Plus: https://plus.google.com/112612135957880308475/about

Twitter: https://twitter.com/LifeSciReports

RSS / Feeds: http://www.lifescienceindustryresearch.com/feed

Contact:
Ritesh Tiwari
TX, Dallas North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas 75252
Tel: +1-888-391-5441
[email protected]

SOURCE Life Science Industry Research